Ajm. Van Boxem et al., Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose?, LUNG CANC, 31(1), 2001, pp. 31-36
The degree of healing and damage of the bronchial wall after photodynamic t
herapy. Nd-YAG laser and electrocautery for intraluminal early-stage cancer
have been analysed. Review of the bronchoscopy reports and follow-up histo
logy specimens of twenty-nine patients treated bronchoscopically with curat
ive intent for their intraluminal tumor have been performed. Seventeen pati
ents had been treated with bronchoscopic electrocautery (BE) only, six with
photodynamic therapy (PDT) and six with Nd-YAG laser. Bronchial wall scarr
ing seen during follow-up bronchoscopy was scored and subepithelial fibrosi
s were histologically evaluated using Alcian blue staining, Azan staining a
nd polarised light. After BE, prominent airway scarring was seen in five pa
tients (29%), with significant stenosis (> 50% lumen) in one of these: case
s. Prominent scarring and significant stenosis were found in four (67%), af
ter PDT. In five (83%) after Nd-YAG laser prominent scarring was found, one
patient had significant stenosis. In three cases, two after BE and one aft
er PDT, subepithelial tissue in the follow-up biopsies was insufficient for
proper histologic examination. In the remaining biopsy specimen only one (
7%) showed a moderate or excessive amount of fibroblasts after BE, whereas
for PDT and Nd-YAG this was found in three (60%) and four patients (67%), r
espectively. Excessive matrix was found in none of the biopsies after BE, i
n two (40%) after PDT and in three (50%) after Nd-YAG laser. Compact collag
en formations were seen in two (12%) biopsies after BE, in two (40 and 33%)
after PDT and Nd-YAG, respectively. Compared to electrocautery, more airwa
y scarring and more subepithelial fibrosis were seen after treatment with P
DT and Nd-YAG laser. These findings, especially regarding PDT, is in contra
st to the assumption that PDT is selective and may be important in the choi
ce of treatment for patients with early stage cancer. (C) 2001 Elsevier Sci
ence Ireland Ltd. All rights reserved.